Learn how viral vector release testing for AAV and lentiviral vectors utilizes orthogonal assays for titer, capsid content, ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

VectorBuilder, a global leader in gene delivery technologies and CDMO services, and MaxCyte, a leading, cell-engineering ...

What is collectively needed, both companies maintain, are more efficient, safer, and scalable approaches to cell engineering.

On track for enrollment of 80 participants by Q1 2027Trial is supported by Phase 2 results showing significant improvement in overall survival in ...

Gene editing and metabolic engineering offer strategies to maintain vitamins and minerals in staple crops as CO₂ levels rise ...

Sangamo Therapeutics, a pioneering gene editing biotech company in the Bay Area, has filed for Chapter 11 bankruptcy protection and agreed to sell some of its programs and platforms to Eli Lilly and ...

All the Nagarro shareholders, we will see an immediate return on their share price. And also, I believe that as we build a scalable and a scaled company over the next few years, Persistent ...

Lymphoma-free survival exceeding 5 years in early recipients of the cellular therapy ...

Before Star Wars became one of arcade gaming’s great classics, it began as a failed 3D space combat experiment. Here’s how ...

VectorBuilder made an agreement with MaxCyte, a biotechnology and electroporation company. The partnership will focus on ...